Covid-19 and neuromuscular diseases

Functional motor performance outcome measures (OM), assessed by Physiotherapists, are commonly used as primary or secondary endpoints in clinical trials, natural history studies and within clinics for children and adults with neuromuscular disorders (NMD). The impact of COVID-19 globally on the ability to assess patients within the clinic, especially those considered clinically vulnerable and advised to shield at home, necessitated rapid development of COVID-19 mitigation strategies. Here we explore the feasibility of adapting current standard outcomes to remote testing, considerations for a remote assessment, methods utilised for clinical evaluator training and future work on validation of the home assessments.
Source: Neuromuscular Disorders - Category: Neurology Authors: Source Type: research